CRNX - Crinetics Pharmaceuticals, Inc.

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 42.12

Open

$ 42.07

Bid

$ 42.07 x 200

Ask

$ 0.00 x 0

Day's Range

$ 41.74 - $ 42.80

52 Week Range

$ 15.76 - $ 49.58

Volume

563,205

Average Volume

Market Cap

2.27B

Beta (5Y Monthly)

$ 0.89

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	11-07-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	02-28-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-12-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-30-2022	12-31-2021	10-K
10	11-05-2021	09-30-2021	10-Q
11	08-10-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	03-30-2021	12-31-2020	10-K
14	11-06-2020	09-30-2020	10-Q
15	08-07-2020	06-30-2020	10-Q
16	05-08-2020	03-31-2020	10-Q
17	03-09-2020	12-31-2019	10-K
18	11-12-2019	09-30-2019	10-Q
19	08-13-2019	06-30-2019	10-Q
20	05-13-2019	03-31-2019	10-Q
21	03-13-2019	12-31-2018	10-K
22	11-13-2018	09-30-2018	10-Q
23	08-30-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Live On CNBC, StemPoint Capital CIO Michel...
04/03/2024 16:40:31

JMP Securities Reiterates Market Outperfor...
03/28/2024 14:41:23

JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and mai...

Oppenheimer Maintains Outperform on Crinet...
03/20/2024 15:52:20

Oppenheimer analyst Leland Gershell maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price...

JMP Securities Maintains Market Outperform...
03/20/2024 13:35:41

JMP Securities analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and rais...

HC Wainwright & Co. Maintains Buy on Crine...
03/20/2024 10:35:16

HC Wainwright & Co. analyst Douglas Tsao maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and raises the pri...

JonesTrading Maintains Buy on Crinetics Ph...
03/20/2024 10:08:30

JonesTrading analyst Lina Kaminski maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and raises the price target ...

Crinetics Pharmaceuticals Inc Files For Re...
03/19/2024 20:43:13

- SEC Filing

endocrine-disease-focused-crinetics-pharmaceuticals-stock-soars-on-tuesday---heres-why

Endocrine Disease-Focused Crinetics Pharma...
03/19/2024 18:48:34

Crinetics Pharmaceuticals unveils PATHFNDR-2 Phase 3 results for paltusotine in acromegaly treatment. Statistically significant...

why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Peraso Shares Are Trading Lower By Ove...
03/19/2024 17:48:27

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

HC Wainwright & Co. Reiterates Buy on Crin...
03/19/2024 16:24:54

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $50...

national-cinemedia-reports-upbeat-results-joins-nordstrom-core--main-and-other-big-stocks-moving-higher-on-tuesday

National CineMedia Reports Upbeat Results,...
03/19/2024 14:03:01

U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.

Market-Moving News for March 19th
03/19/2024 12:41:16

CERS: 64% | Cerus Corporation Announces Its ReCePI Phase 3 Trial Of INTERCEPT Blood System Met Its Primary Efficacy Endpoint; S...

Crinetics Pharmaceuticals Announced Toplin...
03/19/2024 10:06:38

JMP Securities Reiterates Market Outperfor...
03/13/2024 15:25:25

JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and mai...

Oppenheimer Reiterates Outperform on Crine...
03/13/2024 12:34:22

Oppenheimer analyst Leland Gershell reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the pric...

HC Wainwright & Co. Reiterates Buy on Crin...
03/13/2024 11:29:12

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $50...

Crinetics Announces Positive Topline Resul...
03/12/2024 20:26:44

Paltusotine Treatment Demonstrated Rapid and Sustained Reductions in Frequency and Severity of Flushing Episodes and Bowel Move...

HC Wainwright & Co. Maintains Buy on Crine...
03/08/2024 11:36:47

HC Wainwright & Co. analyst Douglas Tsao maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and raises the pri...

Citigroup Initiates Coverage On Crinetics ...
03/06/2024 10:19:27

Citigroup analyst David Lebovitz initiates coverage on Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy rating and announc...

Cantor Fitzgerald Maintains Overweight on ...
03/04/2024 15:29:40

Cantor Fitzgerald analyst Josh Schimmer maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and raises the p...